Evofem Biosciences, Inc.
|
10.35 USD
|
102.802%
|
Arch Therapeutics, Inc.
|
-2.27 USD
|
87.225%
|
CSL Limited
|
2.73 USD
|
110.623%
|
Santhera Pharmaceuticals Holding AG
|
5.95 USD
|
104.874%
|
Regen BioPharma, Inc.
|
0.26 USD
|
211.538%
|
BioStem Technologies, Inc.
|
-0.62 USD
|
53.226%
|
Capstone Therapeutics Corp.
|
-36.39 USD
|
99.203%
|
Qrons Inc.
|
-0.06 USD
|
-397.427%
|
Nascent Biotech, Inc.
|
-0.01 USD
|
-2064.179%
|
Northwest Biotherapeutics, Inc.
|
-0.06 USD
|
-404.348%
|
Oncotelic Therapeutics, Inc.
|
-0.02 USD
|
-1357.286%
|
Skye Bioscience, Inc.
|
-5.37 USD
|
94.6%
|
ProtoKinetix, Incorporated
|
-0.01 USD
|
-2800.0%
|
Rebus Holdings, Inc.
|
-0.03 USD
|
-803.427%
|
Acro Biomedical Co., Ltd.
|
-0.26 USD
|
-11.538%
|
Burzynski Research Institute, Inc.
|
-0.01 USD
|
-2743.137%
|
Genscript Biotech Corporation
|
-0.05 USD
|
-538.767%
|
Neon Bloom, Inc.
|
-0.00 USD
|
-19233.333%
|
Adynxx, Inc.
|
- USD
|
Infinity%
|
Eiger BioPharmaceuticals, Inc.
|
-50.78 USD
|
99.429%
|
Nanobac Pharmaceuticals, Incorporated
|
- USD
|
Infinity%
|
Institute of Biomedical Research Corp.
|
-0.05 USD
|
-463.107%
|
SQZ Biotechnologies Company
|
-2.76 USD
|
89.493%
|
Intellipharmaceutics International Inc.
|
-0.09 USD
|
-231.808%
|
Propanc Biopharma, Inc.
|
-0.02 USD
|
-1123.629%
|
Mesoblast Limited
|
-0.09 USD
|
-225.477%
|
Marizyme, Inc.
|
-1.44 USD
|
79.861%
|
Genus plc
|
0.12 USD
|
341.667%
|
VioQuest Pharmaceuticals, Inc.
|
-2.33 USD
|
87.554%
|
Pharming Group N.V.
|
-0.02 USD
|
-1701.242%
|
Therapeutic Solutions International, Inc.
|
-0.00 USD
|
-41328.571%
|
CNBX Pharmaceuticals Inc.
|
-0.42 USD
|
30.952%
|
Nymox Pharmaceutical Corporation
|
-0.10 USD
|
-200.518%
|
ContraFect Corporation
|
-124.97 USD
|
99.768%
|
PsyBio Therapeutics Corp.
|
-0.04 USD
|
-590.476%
|
Sienna Biopharmaceuticals, Inc.
|
- USD
|
Infinity%
|
RegeneRx Biopharmaceuticals, Inc.
|
-0.01 USD
|
-2316.667%
|
IMV Inc.
|
-4.37 USD
|
93.364%
|
AXIM Biotechnologies, Inc.
|
-0.04 USD
|
-719.209%
|
MultiCell Technologies, Inc.
|
-0.00 USD
|
-289900.0%
|
ONE Bio Corp.
|
1.43 USD
|
120.28%
|
Accustem Sciences Inc.
|
-0.34 USD
|
14.706%
|
RVL Pharmaceuticals plc
|
-0.58 USD
|
50.0%
|
Arno Therapeutics, Inc.
|
- USD
|
Infinity%
|
EV Biologics, Inc.
|
-0.12 USD
|
-141.667%
|
Q BioMed Inc.
|
-0.08 USD
|
-271.319%
|
Emmaus Life Sciences, Inc.
|
-0.07 USD
|
-312.518%
|
Mosaic ImmunoEngineering Inc.
|
-0.33 USD
|
12.121%
|
Biomind Labs Inc.
|
-0.02 USD
|
-1690.123%
|
American Oriental Bioengineering, Inc.
|
-781.24 USD
|
99.963%
|
Provectus Biopharmaceuticals, Inc.
|
-0.01 USD
|
-3818.919%
|
TetraLogic Pharmaceuticals Corporation
|
- USD
|
Infinity%
|
GlobeStar Therapeutics Corporation
|
-0.00 USD
|
-11983.333%
|
THC Farmaceuticals, Inc.
|
-0.00 USD
|
-36150.0%
|
Curative Biotechnology, Inc.
|
-0.01 USD
|
-3195.455%
|
GB Sciences, Inc.
|
-0.00 USD
|
-6973.171%
|
Alpha Cognition Inc.
|
-0.15 USD
|
-93.333%
|
HST Global, Inc.
|
-0.03 USD
|
-939.427%
|
Wesana Health Holdings Inc.
|
-0.05 USD
|
-478.842%
|
Halberd Corporation
|
-0.00 USD
|
-289900.0%
|
Enzolytics Inc.
|
-0.00 USD
|
-41328.571%
|
Agentix Corp.
|
-0.04 USD
|
-728.571%
|
Resverlogix Corp.
|
-0.01 USD
|
-1942.254%
|
Nuo Therapeutics, Inc.
|
-0.08 USD
|
-284.615%
|
MetaStat, Inc.
|
- USD
|
Infinity%
|
argenx SE
|
-5.16 USD
|
94.38%
|
Enzon Pharmaceuticals, Inc.
|
0.00 USD
|
22407.692%
|
Endonovo Therapeutics, Inc.
|
0.03 USD
|
1255.378%
|
RespireRx Pharmaceuticals Inc.
|
-0.04 USD
|
-712.325%
|
GeneThera, Inc.
|
- USD
|
Infinity%
|
Inhibitor Therapeutics, Inc.
|
-0.02 USD
|
-1350.0%
|
AVAX Technologies, Inc.
|
-0.05 USD
|
-438.033%
|
Zenith Capital Corp.
|
-0.07 USD
|
-314.878%
|
Ember Therapeutics, Inc.
|
-0.01 USD
|
-4503.175%
|
Anthera Pharmaceuticals, Inc.
|
- USD
|
Infinity%
|
Sigyn Therapeutics, Inc.
|
-3.77 USD
|
92.308%
|
WPD Pharmaceuticals Inc.
|
-0.00 USD
|
-57900.0%
|
Cotinga Pharmaceuticals Inc.
|
-0.09 USD
|
-217.634%
|
Kadimastem Ltd
|
-0.78 USD
|
62.821%
|
Helix BioMedix, Inc.
|
-4.70 USD
|
93.83%
|
VitaSpring Biomedical Co. Ltd.
|
- USD
|
Infinity%
|
Oncology Pharma Inc.
|
- USD
|
Infinity%
|
Reve Technologies, Inc.
|
-0.01 USD
|
-2336.975%
|
LadRx Corporation
|
0.68 USD
|
142.647%
|
Cell Source, Inc.
|
-0.17 USD
|
-70.588%
|
Regen BioPharma, Inc.
|
0.29 USD
|
200.0%
|
NovAccess Global Inc.
|
-0.23 USD
|
-26.087%
|
Affymax, Inc.
|
-0.39 USD
|
25.641%
|
Itoco Inc.
|
-0.01 USD
|
-3715.789%
|
Rasna Therapeutics, Inc.
|
-0.01 USD
|
-2800.0%
|
Pathfinder Cell Therapy, Inc.
|
-0.00 USD
|
-11500.0%
|
Mobile Lads Corp.
|
-0.01 USD
|
-5078.571%
|
CytoDyn Inc.
|
-0.05 USD
|
-448.204%
|
Claritas Pharmaceuticals, Inc.
|
- USD
|
Infinity%
|
NDT Pharmaceuticals Inc.
|
-0.00 USD
|
-57900.0%
|
NanoSphere Health Sciences Inc.
|
-0.02 USD
|
-1206.306%
|
Alseres Pharmaceuticals, Inc.
|
-153.67 USD
|
99.811%
|
SYBLEU INC
|
-0.02 USD
|
-1557.143%
|
Advanced Proteome Therapeutics Corporation
|
- USD
|
Infinity%
|
ImmunoCellular Therapeutics, Ltd.
|
-0.01 USD
|
-1942.254%
|
International Stem Cell Corporation
|
-0.02 USD
|
-1668.293%
|
Bioxytran, Inc.
|
-0.03 USD
|
-809.091%
|
GlobeImmune, Inc.
|
- USD
|
Infinity%
|
Predictive Technology Group, Inc.
|
- USD
|
Infinity%
|
ProText Mobility, Inc.
|
- USD
|
Infinity%
|
Cardax, Inc.
|
- USD
|
Infinity%
|
VG Life Sciences Inc.
|
-0.00 USD
|
-289900.0%
|
Kaleido Biosciences, Inc.
|
- USD
|
Infinity%
|
Advaxis, Inc.
|
-7.99 USD
|
96.37%
|
Adhera Therapeutics, Inc.
|
-1.18 USD
|
75.424%
|
RenovaCare, Inc.
|
- USD
|
Infinity%
|
Regnum Corp.
|
-0.03 USD
|
-752.941%
|
Innovation Pharmaceuticals Inc.
|
-0.01 USD
|
-4503.175%
|
Neutra Corp.
|
-0.00 USD
|
-289900.0%
|
Windtree Therapeutics, Inc.
|
-94.23 USD
|
99.692%
|
PureTech Health plc
|
-2.38 USD
|
87.815%
|
Coeptis Therapeutics, Inc.
|
-0.83 USD
|
65.06%
|
IXICO plc
|
-0.02 USD
|
-1088.525%
|
IntelGenx Technologies Corp.
|
-0.06 USD
|
-410.563%
|
Gelesis Holdings, Inc.
|
-1.35 USD
|
78.519%
|
CSL Limited
|
5.47 USD
|
105.302%
|
Cellectis S.A.
|
-1.77 USD
|
83.616%
|